We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$175M
AUM Growth
+$15.9M
Cap. Flow
+$4.28M
Cap. Flow %
2.44%
Top 10 Hldgs %
89.06%
Holding
43
New
2
Increased
7
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$2.56M
2
WPM icon
Wheaton Precious Metals
WPM
+$716K
3
OR icon
OR Royalties Inc
OR
+$540K
4
SILV
SilverCrest Metals Inc. Common Shares
SILV
+$394K
5
EQX icon
Equinox Gold
EQX
+$346K

Top Sells

Rank Stock Value
1
AVXL icon
Anavex Life Sciences
AVXL
+$2.6M
2
AG icon
First Majestic Silver
AG
+$434K
3
MAG
MAG Silver
MAG
+$65.1K

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Materials 4%
3 Technology 1.92%
4 Financials 1.38%
5 Industrials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASML icon
26
ASML
ASML
$669B
$609K 0.35%
1,280
– –
WPM icon
27
Wheaton Precious Metals
WPM
$60.9B
$594K 0.34%
+16,500
New +$716K
MAG
28
DELISTED
MAG Silver
MAG
$584K 0.33%
17,300
-4,450
-20% -$65.1K
ABEO icon
29
Abeona Therapeutics
ABEO
$413M
$461K 0.26%
88,630
– –
SA
30
Seabridge Gold
SA
$3.35B
$398K 0.23%
32,000
– –
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$336K 0.19%
5,000
– –
CNTX icon
32
Context Therapeutics
CNTX
$44.5M
$296K 0.17%
139,520
– –
SNGX icon
33
Soligenix
SNGX
$5.81M
$163K 0.09%
1,133
– –
ANVS icon
34
Annovis Bio
ANVS
$80M
$161K 0.09%
14,210
– –
BTAI icon
35
BioXcel Therapeutics
BTAI
$27.8M
$92K 0.05%
1,250
– –
ORMP icon
36
Oramed Pharmaceuticals
ORMP
$179M
$92K 0.05%
20,000
– –
AGTC
37
DELISTED
Applied Genetic Technologies Corporation
AGTC
$77K 0.04%
100,000
– –
ELTX icon
38
Elicio Therapeutics
ELTX
$83.8M
$68K 0.04%
6,000
– –
SPRO icon
39
Spero Therapeutics
SPRO
$73M
$52K 0.03%
70,000
– –
AG icon
40
First Majestic Silver
AG
$9.07B
– –
-33,000
Closed -$434K
AVXL icon
41
Anavex Life Sciences
AVXL
$310M
– –
-210,789
Closed -$2.6M
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Knoll Capital Management held 43 positions worth $175M, up 10% from $159M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Knoll Capital Management's Q2 2022 filing shows 2 new, 7 increased, 1 reduced and 2 closed positions. Its largest new stake was Wheaton Precious Metals: 16,500 shares worth $594K. The largest sale was Anavex Life Sciences, an estimated $2.6M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 86% a quarter earlier, followed by Materials and Technology.

  • Knoll Capital Management's largest Q2 2022 buy was Wheaton Precious Metals: 16,500 shares worth $594K.
  • Knoll Capital Management added most to Aldeyra Therapeutics in Q2 2022, an estimated $2.56M increase.
  • Knoll Capital Management's biggest Q2 2022 reduction was MAG Silver, cutting an estimated $65.1K.
  • Knoll Capital Management fully exited Anavex Life Sciences in Q2 2022, selling an estimated $2.6M.
  • Knoll Capital Management's ten largest holdings make up 89% of its $175M portfolio in Q2 2022.
  • Knoll Capital Management opened 2 new positions and closed 2 in Q2 2022.
  • Knoll Capital Management's portfolio value rose 10% quarter-over-quarter to $175M.

Based on Knoll Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.